Discovery of novel olaparib-β-carboline hybrids for treating BRCA-deficient triple negative breast cancer

Bioorganic & Medicinal Chemistry 2026

View at publisher

Authors: Xiaojuan Yang, Tong Shen, Liqiang Wu

DOI: 10.1016/j.bmc.2026.118585

Cited by: 1

References: 42

Fields of Study & Subjects

PARP inhibition in cancer therapy Synthesis and bioactivity of alkaloids Advanced Breast Cancer Therapies

References 42